Magnésium Bisglycinate 07.2026
Food supplement declared in France, decision dated 1 August 2026
Magnésium Bisglycinate 07.2026 (Umami) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Magnesium, Nicotinamide (vitamin B3), Vitamin B2 (riboflavin), Vitamin B6. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Umami
- Food business operator placing the product on the market
- LIEMA
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 4
- Intended populations
- Men and women aged 18 and over
- Objectives stated by the manufacturer (these are not authorised claims)
- Sleep, Sport, Mood, Nervous system
Declaration 372334, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| magnesium bisglycinate | Magnesium | 250 mg | 300 mg |
| nicotinamide | Nicotinamide (vitamin B3) | 900 mg | 54 mg |
| Riboflavine 5'-phosphate | Vitamin B2 (riboflavin) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| pyridoxine hydrochloride | Vitamin B6 | 12 mg | 2 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Umami
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Magnésium Bisglycinate 07.2026 (Umami): composition and regulation”, https://compoatlas.com/en/supplements/products/372334-magnesium-bisglycinate-07-2026, updated 15 November 2026.